Cell survival was significantly suppressed in KRT19-overexpressing cells as compared to those of vector-infected KU-CSLC cells (Figure 5C), implying that KRT19 may regulate drug-sensitivity in highly drug-resistant breast cancer stem cell-like cells. The gene discussed is KRT19; the disease is breast cancer.